Related Scientific Publications
1. Sundaram RK, Kasinathan C, Stein S, Sundaram P. Detoxification depots for beta amyloid. Curr. Alz. Res. 2008, 5: 26-32.
2. Sundaram RK, Kasinathan C, Stein S and Sundaram P. Novel detox gel depot sequesters β- Amyloid Peptides in a mouse model of Alzheimer's disease. Int. J. Pept. Res. Ther. 2012, 18: 99-106.
3. Sundaram P., Nambiar, A.K and Sundaram RK. Patents on potential drugs to treat Alzheimer's Disease: Special emphasis on small peptides. Recent Patents on CNS Drug Discovery, 2014, 9: 71-75
4. Srinivas K, Shanmugasundaram KR, Misra KP, Sankaran JR, Sundaram P. Plasma lipids and lipoprotein profile in coronary heart disease and in healthy volunteers in South India. Nutrition Reports Int. 1989; 39: 567-74.
5. Shanmugasundaram ERB, Sundaram P, Srinivas K, Sankaran JR, Shanmugasundaram KR. Double blind cross over study of Modified Anna Pavala Sindhooram in patients with hyperlipidemia or ischemic heart disease. J Ethnopharmacology 1991; 31: 85-99.
6. Sundaram P. Sialic acid and its analogues as potential neuro anti-inflammatory therapeutic candidates for Alzheimer's disease. Brain and Nerves 2017, 1: 1-4. doi: 10.15761/JBN.1000114
7.Gandbhir O and Sundaram P. 'Amytrapper', a Novel Immobilized Sepharose API Matrix, Removes Amyloid-β from Circulation in vitro. J Alz. Dis. Rep. 2019, 3: 19-29.
8.Gandbhir O and Sundaram P. Preclinical safety and efficacy evaluation of Amytrap, a novel therapeutic to treat Alzheimer's Disease. J Alz. Dis. Rep. 2019, 3: 77-94.
9.Gandbhir O and Sundaram P. Effect of Amytrap, an amyloid - B binding drug, on AB induced mitochondrial dysfunction and phosphorylation in cultured neuroblastoma cells. Metab. Brain. Dis. 2020, 35: 923-931.
10. Chhipa, RR, Gandbhir, O, Le, H, Sankar, S and Sundaram, P.
J Alzheimer's Neurodegener Dis 2021, 7: 055 DOI: 10.24966/AND-9608/100055 .